Evidence map›Paper›PMID 41015045›Full record

ArticleCell host & microbe2025

A Bacteroides fragilis protease activates host PAR

Markus Lakemeyer, Rocco Latorre, Kristyna Blazkova, Hannah M Wood, Dane D Jensen, Nayab Shakil, Scott C Thomas, Deepak Saxena, Yatendra Mulpuri, David Poolman and 9 more

Abstract read
In one paragraph

Article in Cell host & microbe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. A Review on the Molecular Dynamics of EnterotypeInternational journal of molecular sciences · 2026
    Review
  8. Article
  9. Article
  10. Proteases and Abdominal Pain-Old Dog, New (Microbial) Tricks.Cellular and molecular gastroenterology and hepatology · 2026
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Markus LakemeyerInstitute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany; Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, 07743 Jena, Germany; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: markus.lakemeyer@uni-jena.de.
Rocco LatorreDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA; Pain Research Center, NYU Dentistry, New York, NY 10010, USA.
Kristyna BlazkovaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Hannah M WoodGastrointestinal Diseases Research Unit, Queen's University, Kingston, ON K7L 3N6, Canada.
Dane D JensenDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA; Pain Research Center, NYU Dentistry, New York, NY 10010, USA; Translational Research Center, NYU Dentistry, New York, NY 10010, USA; Department of Oral and Maxillofacial Surgery, NYU Dentistry, Bluestone Center for Clinical Research, New York, NY 10010, USA.
Nayab ShakilInstitute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.
Scott C ThomasDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA.
Deepak SaxenaDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA.
Yatendra MulpuriDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA.
David PoolmanDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA; Pain Research Center, NYU Dentistry, New York, NY 10010, USA.
Paz DuranDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA; Pain Research Center, NYU Dentistry, New York, NY 10010, USA; Translational Research Center, NYU Dentistry, New York, NY 10010, USA; Department of Oral and Maxillofacial Surgery, NYU Dentistry, Bluestone Center for Clinical Research, New York, NY 10010, USA.
Laura J KellerDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
David E ReedGastrointestinal Diseases Research Unit, Queen's University, Kingston, ON K7L 3N6, Canada.
Brian L SchmidtDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA; Pain Research Center, NYU Dentistry, New York, NY 10010, USA; Translational Research Center, NYU Dentistry, New York, NY 10010, USA; Department of Oral and Maxillofacial Surgery, NYU Dentistry, Bluestone Center for Clinical Research, New York, NY 10010, USA.
Néstor N Jiménez-VargasGastrointestinal Diseases Research Unit, Queen's University, Kingston, ON K7L 3N6, Canada.
Fangxi XuDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA.
Alan E LomaxGastrointestinal Diseases Research Unit, Queen's University, Kingston, ON K7L 3N6, Canada.
Nigel W BunnettDepartment of Molecular Pathobiology, NYU Dentistry, New York, NY 10010, USA; Pain Research Center, NYU Dentistry, New York, NY 10010, USA. Electronic address: nwb2@nyu.edu.
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: mbogyo@stanford.edu.

Funding

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseasesR01DK130293 · NIDDK · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2021 to 2025
$2.4M
Mechanisms of Endosomal Signaling of ItchR01NS125413 · NINDS · NEW YORK UNIVERSITY · PI Dane D Jensen · 2022 to 2026
$1.9M
A Modern Flexible Mass Spectrometry Platform for Advancing Proteomics ResearchS10OD030473 · OD · STANFORD UNIVERSITY · PI LEIB, RYAN D. · 2021 to 2021
$1.3M
Stanford Chem-H Chemistry/Biology Interface Predoctoral Training ProgramT32GM120007 · NIGMS · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN · 2016 to 2020
$1.2M
Molecular Pharmacology Training GrantT32GM113854 · NIGMS · STANFORD UNIVERSITY · PI MOCHLY-ROSEN, DARIA · 2015 to 2019
$1.1M
NIDDK NIH HHS R01 DK130293NIGMS NIH HHS T32 GM113854NIGMS NIH HHS T32 GM120007NIH HHS S10 OD030473NINDS NIH HHS R01 NS125413
6 · The paper itself

Abstract

Protease-activated receptor 2 (PAR

Indexed as

Bacterial ProteinsBacteroides fragilisInflammationReceptor, PAR-2Serine ProteasesAnimalsDisease Models, AnimalGastrointestinal MicrobiomeHumansInflammatory Bowel DiseasesIrritable Bowel SyndromeMaleMiceMice, Inbred C57BLBacterial ProteinsF2rl1 protein, mouseReceptor, PAR-2Serine Proteasesactivity-based probegut microbiotainflammationinflammatory bowel diseaseintestinal organoidsirritable bowel syndromepain signalingproteaseprotease-activated receptors

Identifiers

PMID41015045
PMCPMC12919672

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.